Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of GLP-1 in Congenital Hyperinsulinism:Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity

NCT00897676 is registered in ClinicalTrials.gov with Diva De Leon as lead sponsor.

NCT NCT00897676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00897676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of GLP-1 in Congenital Hyperinsulinism:Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity
Lead sponsor
Diva De Leon
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2009
Completion date
January 31, 2017
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital hyperinsulinism